Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer Patients
- Status
- RECRUITING
- Phase
- NA
GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Status
- RECRUITING
- Phase
- PHASE1
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
- Status
- RECRUITING
- Phase
- PHASE3
A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
H101 Plus TACE for r/m HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Becotatug Vedotin Plus Pucotenlimab and Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
First in Human Study of QLS5316 in Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
First in Human Study of SIM0610 in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
ABY-029 Head & Neck Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2